The Foundry
The Foundry is a Menlo Park-based medical device incubator founded in 1998 that forms, funds, and operates companies developing category-defining medical technologies, having created 20+ portfolio companies and $3B+ in shareholder value through strategic exits.
- Company typePrivate
- Founded1998
- HeadquartersMenlo Park, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What The Foundry does
The Foundry, LLC is a privately held medical device and biotechnology incubator founded in 1998 in Menlo Park, California, that identifies unmet clinical needs and forms, funds, and operates companies to commercialize innovative medical technologies. The firm operates a portfolio-based platform rather than a single product line, having developed more than 20 companies since inception across cardiovascular (Ardian, Twelve, Mavericks Endo, Half Moon Medical), neurovascular/stroke (Concentric Medical), structural heart (Evalve/MitraClip), pulmonary/respiratory (Emphasys/Zephyr, Nuvaira, Apreo Health), pain management (Allay Therapeutics), drug delivery (Foundry Therapeutics), ophthalmology (ForSight Labs, Transcend Medical, ForSight Vision2), and aesthetics (Cabochon, Miramar Labs) verticals. Its underlying technology stack consists of an integrated R&D infrastructure located at its Menlo Park headquarters — including wet lab, chemistry development facility, machine shop, and clean room — combined with a team of operating partners and a 500+ patent portfolio that has produced multiple category-defining devices now standard-of-care.
The Foundry generates revenue primarily through equity ownership in its portfolio companies, with exits typically occurring via acquisition by strategic medical device companies (Medtronic acquired Ardian for $850M in 2011 and Twelve for $458M in 2015; Abbott acquired Evalve for $410M in 2009; Stryker acquired Concentric Medical for $135M in 2011; Pulmonx acquired Emphasys in 2009). Portfolio companies have collectively raised approximately $1B from more than 50 venture capital firms and corporations, generating over $3B in aggregate shareholder value. Customers of the underlying therapies are hospitals, physicians, and patients; the firm itself sells nothing directly to end users. Active development-stage companies include Allay Therapeutics, Apreo Health, Mavericks Endo, FIRE1 (Dublin), Foundry Therapeutics, Nuvaira, and Half Moon Medical, with the Half Moon Medical program operating under a strategic development partnership with Medtronic. The company employs 1-10 people at the parent-entity level and is led by Managing Partner Hanson S. Gifford III, a named inventor on 370+ US patents.
The Foundry firmographics
Firmographics- Name
- The Foundry
- Legal name
- The Foundry, LLC
- Website
- https://thefoundry.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- The Foundry is a Menlo Park-based medical device incubator founded in 1998 that forms, funds, and operates companies developing category-defining medical technologies, having created 20+ portfolio companies and $3B+ in shareholder value through strategic exits.
- Ownership category
- akta.pro rank
The Foundry industry classification
Industry- Product category
- Medical Device Incubation Services
- NAICS
- Machinery Manufacturing (333)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Process Development & Tech Transfer Services (CDMO) (HLAGABAL)
- akta.pro secondary industries
- Process Development & Tech Transfer (Upstream/Downstream/MSAT) (HLAGAGAE), CMC, Process Development & Tech Transfer Staffing FSP (HLAGAOAK)
Keywords
Where The Foundry is headquartered
LocationHeadquarters
- HQ city
- Menlo Park
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
The Foundry business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Equity stakes in portfolio companies: The Foundry generates returns through equity ownership in the companies it develops and incubates. Companies are formed around innovative medical technologies and typically raised funding from VCs and corporations before being acquired by major medical device companies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
The Foundry product offering
Product offeringCore offering
The Foundry is a medical device company incubator that identifies unmet clinical needs and builds independent companies around innovative medical technologies. The firm provides integrated R&D facilities (wet lab, chemistry development, machine shop, clean room), an experienced leadership team, funding capabilities, and an extensive network of VCs and strategic partners to take technologies from concept through development, clinical milestones, and ultimately acquisition or commercialization.
Product overview
The Foundry is a medical technology incubator that identifies unmet clinical needs and builds companies around innovative technologies that address them. Rather than a single unified product, The Foundry operates as a portfolio-based platform that has developed over 20 medical device and biotechnology companies since 1998. The core products include landmark medical devices such as the Symplicity Catheter System (by Ardian), Zephyr Valve (by Emphasys Medical), Merci Retriever (by Concentric Medical), and MitraClip (by Evalve) - all of which have been successfully acquired by major medical device companies. The portfolio spans multiple therapeutic areas including cardiovascular, stroke/neurovascular, respiratory/pulmonary, ophthalmology, pain management, and medical aesthetics. The portfolio companies include legacy companies (like Ardian, Concentric Medical, Evalve, Emphasys Medical that were acquired) and active companies (like Allay Therapeutics, Apreo Health, FIRE1, Nuvaira, Half Moon Medical, Mavericks Endo). The Foundry provides facilities, expertise, and resources to develop these technologies from concept to market.
Differentiator
Problem solved
Functional benefit
Products and services
- The Foundry Medical Device Incubation Service
- Allay Therapeutics
- Apreo Health
- FIRE1
- Foundry Therapeutics
- Half Moon Medical
- Mavericks Endo
- Nuvaira
Quantifiable outcome
- $3B+ in shareholder value created
- +3 more outcomes
Companies that use The Foundry
Customer profileNamed customers5 records
Segments1 record
Ideal customer profiles2 records
The Foundry technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
The Foundry partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- MedtroniccoreMedtronic announced a partnership with The Foundry in October 2020 to develop innovative mitral valve repair technology. Half Moon Medical's technology was being evaluated in an early feasibility study. This builds on The Foundry's history with Medtronic, which has acquired multiple Foundry portfolio companies including Ardian and Twelve.
- Covidien VenturescoreFIRE1 was formed in 2014 as a partnership with Covidien Ventures to develop a heart failure monitoring solution which measures circulating blood volume to improve outcomes for heart failure patients. FIRE1 is based in Dublin, Ireland.
- Dr. Eugene de Juan, Jr. and K. Angela MacfarlanecoreForSight Labs, an ophthalmic company incubator, was formed in 2005 in partnership with Dr. Eugene de Juan, Jr. and K. Angela Macfarlane. Six companies were formed to develop treatments for glaucoma, retinal diseases, conjunctivitis and dry eye.
- Medtronic (Half Moon Medical)coreHalf Moon Medical was formed in 2017 in partnership with Medtronic to develop a transcatheter device for mitral valve repair to restore function in patients with severe symptomatic mitral regurgitation.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
The Foundry competitors and assessment
Company assessmentDirect peers
- InCube Labs: Medical device and combination-product incubator founded by Mir Imran in the San Francisco Bay Area. Operates a similar concept-to-company model with integrated R&D facilities and equity stakes in portfolio companies, making it the closest comparable to The Foundry.
- Synecor: Medical device incubator co-founded by many of the same individuals involved in The Foundry's ecosystem. Builds and invests in early-stage medical device companies with a comparable lab-to-company approach.
- ExploraMed: Medical device incubator founded by Josh Makower that created multiple companies later acquired by Covidien/Medtronic (e.g., NeoTract). Direct structural peer in the medical-device company-building model.
- ForSight Labs: Ophthalmic company incubator formed in 2005 in partnership with The Foundry itself. Operates the same incubator model in a narrower ophthalmology vertical, making it a direct intra-portfolio comparable.
Emerging players
- Nualas: Early-stage medical device incubator with a similar company-formation model focused on unmet clinical needs. Smaller and less proven than The Foundry, but operates on a comparable playbook.
Broad incumbents
- Longitude Capital: Healthcare-focused venture capital firm with active medical device practice. While primarily a fund rather than an incubator, it co-invests in similar early-stage medical device companies and provides comparable capital deployment.
Others
- Lightstone Ventures: Healthcare and medical device venture capital firm where The Foundry's Managing Partner Hanson Gifford also serves as a Partner. Direct ecosystem overlap makes it a relevant adjacent peer.
- New Enterprise Associates (NEA): Major venture capital firm with disclosed investment activity in The Foundry-affiliated portfolio companies (2013 and 2018 funding rounds). Represents a key financial partner in The Foundry's portfolio.
- Domain Associates: Healthcare-focused venture firm that co-invested in The Foundry-affiliated portfolio company funding rounds (2010). Relevant as a recurring financial partner in the Foundry ecosystem.
- Versant Ventures: Healthcare venture capital firm that participated in The Foundry-affiliated portfolio company financing rounds (2010). Functions as an enabling financial peer in the same company-building ecosystem.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
The Foundry social profiles
Digital presenceThe Foundry financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Foundry leadership team
Management profileNumber of profiles
Profiles4 records
The Foundry subsidiaries and ownership
Company hierarchySubsidiaries6 records
The Foundry funding detail
Funding detailFunding overview
Funding rounds3 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Foundry M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Foundry
What does The Foundry do?
The Foundry is a medical device company incubator that identifies unmet clinical needs and builds independent companies around innovative medical technologies. The firm provides integrated R&D facilities (wet lab, chemistry development, machine shop, clean room), an experienced leadership team, funding capabilities, and an extensive network of VCs and strategic partners to take technologies from concept through development, clinical milestones, and ultimately acquisition or commercialization.
Is The Foundry a public or private company?
The Foundry is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was The Foundry founded?
The Foundry was founded in 1998. It employs 1 to 10 people.
Where is The Foundry based?
The Foundry is headquartered in Menlo Park, United States, in the North America region.
How does The Foundry make money?
One revenue line is on record: equity stakes in portfolio companies.
Who are The Foundry's main competitors?
Direct peers on record are InCube Labs, Synecor, ExploraMed and ForSight Labs. Nualas is listed as an emerging player. Longitude Capital is listed as a broad incumbent. Others are Lightstone Ventures, New Enterprise Associates (NEA), Domain Associates and Versant Ventures.
Does The Foundry have an API?
No public API is recorded for The Foundry.
What industry is The Foundry in?
The Foundry's product category is Medical Device Incubation Services. Its primary akta.pro industry code is HLAGABAL, Process Development & Tech Transfer Services (CDMO), with a secondary code of HLAGAGAE, Process Development & Tech Transfer (Upstream/Downstream/MSAT). Its NAICS code is 333 and its SIC code is 8731.